News

Cell TherapiesR&D project spotlight: A collaborative approach to developing a universal ddPCR™ assay to detect residual pluripotent stem cells in cell therapy products
Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2026202520242023 →
Press release: Achilles Therapeutics to set up manufacturing operations at the CGT Catapult manufacturing centrePress release: Achilles Therapeutics to set up manufacturing operations at the CGT Catapult manufacturing centrePress release: CiRA Foundation and the Cell and Gene Therapy Catapult set to launch new stem cell collaborative researchPress release: CiRA Foundation and the Cell and Gene Therapy Catapult set to launch new stem cell collaborative researchRegulatory news - April 2020Regulatory news - April 2020April news: UK cell and gene therapy manufacturing excellenceApril news: UK cell and gene therapy manufacturing excellenceMarch news: Operations continue at the Cell and Gene Therapy CatapultMarch news: Operations continue at the Cell and Gene Therapy CatapultRegulatory news - March 2020Regulatory news - March 2020February news: Upskilling the UK cell and gene therapy industryFebruary news: Upskilling the UK cell and gene therapy industryCGT Catapult launch new online cell confluency tool to improve consistency in cell cultureCGT Catapult launch new online cell confluency tool to improve consistency in cell cultureRegulatory news - February 2020Regulatory news - February 2020January news: Evolving UK cell and gene therapy clinical trial landscapeJanuary news: Evolving UK cell and gene therapy clinical trial landscapeDecember news: Optimising clinical adoption of advanced therapies in the UKDecember news: Optimising clinical adoption of advanced therapies in the UKNovember news: Accelerating cell and gene therapies towards commercialisationNovember news: Accelerating cell and gene therapies towards commercialisation